Cell-mediated drug delivery
Open accessThe DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Drug targeting to sites of tissue injury, tumor or infection with limited toxicity is the goal for successful pharmaceutics. Immunocytes (including mononuclear phagocytes (dendritic cells, monocytes and macrophages), neutrophils and lymphocytes) are highly mobile; they can migrate across impermeable barriers and release their drug cargo at sites of infection or tissue injury. Thus, immune cells can be exploited as Trojan horses for drug delivery. AREAS COVERED: This paper reviews how immunocytes laden with drugs can cross the blood-brain or blood-tumor barriers to facilitate treatments for infectious diseases, injury, cancer, or inflammatory diseases. The promises and perils of cell-mediated drug delivery are reviewed, with examples of how immunocytes can be harnessed to improve therapeutic end points. EXPERT OPINION: Using cells as delivery vehicles enables targeted drug transport and prolonged circulation times, along with reductions in cell and tissue toxicities. Such systems for drug carriage and targeted release represent a new disease-combating strategy being applied to a spectrum of human disorders. The design of nanocarriers for cell-mediated drug delivery may differ from those used for conventional drug delivery systems; nevertheless, engaging different defense mechanisms in drug delivery may open new perspectives for the active delivery of drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone marrow cells regenerate infarcted myocardium
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., Pickel, J., McKay, R., Nadal-Ginard, B., Bodine, D. M., et al. (2001) · Nature · doi:10.1038/35070587 · Cited by 5,155
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316 · cited 1×
“In addition, several methods of packaging in minicells of a range of anticancer chemotherapeutic drugs, such as doxorubicin, paclitaxel, irinotecan, 5-FLU, cisplatin, carboplatin monastrol and vinblastine, despite their disparate structure, charge, hydrophobicity and solubility, were developed [99-101].”
BackgroundPoly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
Knop, K., Hoogenboom, R., Fischer, D., & Schubert, U. S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200902672 · Cited by 3,533 · cited 1×
“Electrostatically neutral and hydrophilic poly(ethylene glycol) (PEG) is perhaps the most common shell-forming polymer now used in injectable nanocarriers [30-32].”
BackgroundBiodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Mobilized bone marrow cells repair the infarcted heart, improving function and survival
Orlic, D., Kajstura, J., Chimenti, S., Limana, F., Jakoniuk, I., Quaini, F., Nadal-Ginard, B., Bodine, D. M., Leri, A., & Anversa, P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181177898 · Cited by 2,086
Söllner, T., Bennett, M. K., Whiteheart, S. W., Scheller, R. H., & Rothman, J. E. (1993) · Cell · doi:10.1016/0092-8674(93)90376-2 · Cited by 1,896
Pharmacokinetics of Pegylated Liposomal Doxorubicin: Review of Animal and Human Studies
Gabizon, A., Shmeeda, H., & Barenholz, Y. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342050-00002 · Cited by 1,634
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Nanosuspensions as particulate drug formulations in therapy
Müller, R. H., Jacobs, C., & Kayser, O. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00118-6 · Cited by 1,370
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
Multidrug efflux pumps of gram-negative bacteria
Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.20.5853-5859.1996 · Cited by 1,082
Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas
Nakamizo, A., Marini, F., Amano, T., Khan, A., Studeny, M., Gumin, J., Chen, J., Hentschel, S., Vecil, G., Dembinski, J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1874 · Cited by 1,035
Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery
Hofstetter, C. P., Schwarz, E. J., Hess, D., Widenfalk, J., El Manira, A., Prockop, D. J., & Olson, L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042678299 · Cited by 967
(2002) · PubMed · Cited by 903
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
Blurton-Jones, M., Kitazawa, M., Martinez-Coria, H., Castello, N. A., Müller, F.-J., Loring, J. F., Yamasaki, T. R., Poon, W. W., Green, K. N., & LaFerla, F. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901402106 · Cited by 860
Studeny, M., Marini, F. C., Dembinski, J. L., Zompetta, C., Cabreira-Hansen, M., Bekele, B. N., Champlin, R. E., & Andreeff, M. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh299 · Cited by 842
Making polymeric micro- and nanoparticles of complex shapes
Champion, J. A., Katare, Y. K., & Mitragotri, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705326104 · Cited by 747
Torchilin, V. P. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00166-4 · Cited by 680
Harada, A., & Kataoka, K. (1999) · Science · doi:10.1126/science.283.5398.65 · Cited by 598
Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model
Nakamura, K., Ito, Y., Kawano, Y., Kurozumi, K., Kobune, M., Tsuda, H., Bizen, A., Honmou, O., Niitsu, Y., & Hamada, H. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302276 · Cited by 597 · cited 1×
“Cell-mediated delivery is also a potential therapeutic and diagnostic strategy for cancer [46,50,85-93].”
BackgroundA Cellular Trojan Horse for Delivery of Therapeutic Nanoparticles into Tumors
Choi, M.-R., Stanton-Maxey, K. J., Stanley, J. K., Levin, C. S., Bardhan, R., Akin, D., Badve, S., Sturgis, J., Robinson, J. P., Bashir, R., et al. (2007) · Nano Letters · doi:10.1021/nl072209h · Cited by 584
Polymer hollow particles with controllable holes in their surfaces
Hyuk Im, S., Jeong, U., & Xia, Y. (2005) · Nature Materials · doi:10.1038/nmat1448 · Cited by 547
Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage
Tabata, Y., & Ikada, Y. (1988) · Biomaterials · doi:10.1016/0142-9612(88)90033-6 · Cited by 538
Miller, C. R., Bondurant, B., McLean, S. D., McGovern, K. A., & O'Brien, D. F. (1998) · Biochemistry · doi:10.1021/bi980096y · Cited by 524
Juliano, R. L., & Stamp, D. (1975) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(75)80433-5 · Cited by 522
Polymeric Micelles for Delivery of Poorly Water-Soluble Compounds
Kwon, G. S. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i5.20 · Cited by 502 · cited 2×
“It is surrounded with a polymer shell (or lipids in liposomes and lipid nanoparticles), which defines the nanocarrier dispersion stability, circulation time and cell interactions [1-8,10,11,13,14,17,18].”
BackgroundMahmood, A., Lu, D., Lu, M., & Chopp, M. (2003) · Neurosurgery · doi:10.1227/01.neu.0000079333.61863.aa · Cited by 478
Kabanov, A. V., & Alakhov, V. Y. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i1.10 · Cited by 447
Self-citationLong-circulating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D'Angelo, J., Noel, J.-P., Georgin, D., Fattal, E., Andreux, J. P., & Couvreur, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1010931127745 · Cited by 443 · cited 2×
“It is surrounded with a polymer shell (or lipids in liposomes and lipid nanoparticles), which defines the nanocarrier dispersion stability, circulation time and cell interactions [1-8,10,11,13,14,17,18].”
BackgroundNanogels for Oligonucleotide Delivery to the Brain
Vinogradov, S. V., Batrakova, E. V., & Kabanov, A. V. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034164r · Cited by 377
Self-citationLow, W. C., Lewis, P. R., Terri Bunch, S., Dunnett, S. B., Thomas, S. R., Iversen, S. D., Björklund, A., & Stenevi, U. (1982) · Nature · doi:10.1038/300260a0 · Cited by 316
MacDiarmid, J. A., Mugridge, N. B., Weiss, J. C., Phillips, L., Burn, A. L., Paulin, R. P., Haasdyk, J. E., Dickson, K.-A., Brahmbhatt, V. N., Pattison, S. T., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.03.012 · Cited by 307
Åkerud, P., Canals, J. M., Snyder, E. Y., & Arenas, E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08108.2001 · Cited by 305
Kabanov, A. V., Chekhonin, V. P., Alakhov, V. Y., Batrakova, E. V., Lebedev, A. S., Melik-Nubarov, N. S., Arzhakov, S. A., Levashov, A. V., Morozov, G. V., Severin, E. S., et al. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81689-8 · Cited by 296
Self-citationThe macrophage capacity for phagocytosis
Cannon, G. J., & Swanson, J. A. (1992) · Journal of Cell Science · doi:10.1242/jcs.101.4.907 · Cited by 289
Persidsky, Y., Ghorpade, A., Rasmussen, J., Limoges, J., Liu, X. J., Stins, M., Fiala, M., Way, D., Kim, K. S., Witte, M. H., et al. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65476-4 · Cited by 284
Self-citationGene therapy: can neural stem cells deliver?
Müller, F.-J., Snyder, E. Y., & Loring, J. F. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1829 · Cited by 274
MacDiarmid, J. A., Amaro-Mugridge, N. B., Madrid-Weiss, J., Sedliarou, I., Wetzel, S., Kochar, K., Brahmbhatt, V. N., Phillips, L., Pattison, S. T., Petti, C., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1547 · Cited by 272
Lossinsky, A. S., & Shivers, R. R. (2004) · PubMed · doi:10.14670/hh-19.535 · Cited by 272
Water-Soluble Block Polycations as Carriers for Oligonucleotide Delivery
Kabanov, A. V., Vinogradov, S. V., Suzdaltseva, Y. G., & Alakhov, V. Y. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00036a001 · Cited by 255
Self-citationMesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma
Sonabend, A. M., Ulasov, I. V., Tyler, M. A., Rivera, A. A., Mathis, J. M., & Lesniak, M. S. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0758 · Cited by 254
Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery
Dou, H., Destache, C. J., Morehead, J. R., Mosley, R. L., Boska, M. D., Kingsley, J., Gorantla, S., Poluektova, L., Nelson, J. A., Chaubal, M., et al. (2006) · Blood · doi:10.1182/blood-2006-03-012534 · Cited by 253
Self-citationAnthony, D. (1997) · Brain · doi:10.1093/brain/120.3.435 · Cited by 252
Vinogradov, S., Batrakova, E., & Kabanov, A. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00080-6 · Cited by 247
Self-citationMacrophages and neurodegeneration
Hendriks, J. J. A., Teunissen, C. E., de Vries, H. E., & Dijkstra, C. D. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.008 · Cited by 243
Lee, K.-D., Hong, K., & Papahadjopoulos, D. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90086-2 · Cited by 240
Self-Assembled Peptide Amphiphile Nanofibers Conjugated to MRI Contrast Agents
Bull, S. R., Guler, M. O., Bras, R. E., Meade, T. J., & Stupp, S. I. (2005) · Nano Letters · doi:10.1021/nl0484898 · Cited by 237
Dou, H., Grotepas, C. B., McMillan, J. M., Destache, C. J., Chaubal, M., Werling, J., Kipp, J., Rabinow, B., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900274 · Cited by 237
Self-citationNishikawa, K., Arai, H., & Inoue, K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)34110-9 · Cited by 232
Inflammation in the nervous system
Perry, V. H., Bell, M. D., Brown, H. C., & Matyszak, M. K. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80069-7 · Cited by 228
Treatment of Parkinson's disease.
Hardie, R. J. (1985) · PubMed · Cited by 218
Blamire, A. M., Anthony, D. C., Rajagopalan, B., Sibson, N. R., Perry, V. H., & Styles, P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-21-08153.2000 · Cited by 210
A Macrophage−Nanozyme Delivery System for Parkinson's Disease
Batrakova, E. V., Li, S., Reynolds, A. D., Mosley, R. L., Bronich, T. K., Kabanov, A. V., & Gendelman, H. E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc700184b · Cited by 209
Self-citationStoff-Khalili, M. A., Rivera, A. A., Mathis, J. M., Banerjee, N. S., Moon, A. S., Hess, A., Rocconi, R. P., Numnum, T. M., Everts, M., Chow, L. T., et al. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9449-8 · Cited by 205
Outer Membranes and Efflux: The Path to Multidrug Resistance in Gram- Negative Bacteria
Poole, K. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378454 · Cited by 198
Daleke, D. L., Hong, K., & Papahadjopoulos, D. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90365-u · Cited by 193
Macrophage Delivery of Therapeutic Nanozymes in A Murine Model of Parkinson‘S Disease
Brynskikh, A. M., Zhao, Y., Mosley, R. L., Li, S., Boska, M. D., Klyachko, N. L., Kabanov, A. V., Gendelman, H. E., & Batrakova, E. V. (2010) · Nanomedicine · doi:10.2217/nnm.10.7 · Cited by 190
Self-citationMenon, L. G., Kelly, K., Yang, H. W., Kim, S.-K., Black, P. M., & Carroll, R. S. (2009) · Stem Cells · doi:10.1002/stem.136 · Cited by 185
Thiele, L., Merkle, H. P., & Walter, E. (2003) · Pharmaceutical Research · doi:10.1023/a:1022271020390 · Cited by 183
Mizushima, Y., Hamano, T., & Yokoyama, K. (1982) · Annals of the Rheumatic Diseases · doi:10.1136/ard.41.3.263 · Cited by 166
RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting
Jain, S., Mishra, V., Singh, P., Dubey, P. K., Saraf, D. K., & Vyas, S. P. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00269-2 · Cited by 164
Molecular flypaper and atherosclerosis: structure of the macrophage scavenger receptor
Krieger, M. (1992) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(92)90322-z · Cited by 164
Gbadamosi, J. K., Hunter, A. C., & Moghimi, S. M. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03710-9 · Cited by 150
Nanoparticulate Cellular Patches for Cell-Mediated Tumoritropic Delivery
Cheng, H., Kastrup, C. J., Ramanathan, R., Siegwart, D. J., Ma, M., Bogatyrev, S. R., Xu, Q., Whitehead, K. A., Langer, R., & Anderson, D. G. (2010) · ACS Nano · doi:10.1021/nn901319y · Cited by 145
Ikehara, Y., Niwa, T., Biao, L., Ikehara, S. K., Ohashi, N., Kobayashi, T., Shimizu, Y., Kojima, N., & Nakanishi, H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0470 · Cited by 140
NanoART, NeuroAIDS and CNS Drug Delivery
Nowacek, A. S., & Gendelman, H. E. (2009) · Nanomedicine · doi:10.2217/nnm.09.38 · Cited by 140
Self-citationGarcia, P., Youssef, I., Utvik, J. K., Florent-Béchard, S., Barthélémy, V., Malaplate-Armand, C., Kriem, B., Stenger, C., Koziel, V., Olivier, J.-L., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4182-09.2010 · Cited by 139 · cited 1×
“NSCs Ciliary neurotrophic factor Intracranial injection [73]”
Jaturanpinyo, M., Harada, A., Yuan, X., & Kataoka, K. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034149m · Cited by 139
Neurorescue effects of VEGF on a rat model of Parkinson's disease
Yasuhara, T., Shingo, T., Muraoka, K., Kameda, M., Agari, T., Ji, Y., Hayase, H., Hamada, H., Borlongan, C. V., & Date, I. (2005) · Brain Research · doi:10.1016/j.brainres.2005.05.027 · Cited by 136
Nowacek, A. S., Miller, R. L., McMillan, J., Kanmogne, G., Kanmogne, M., Mosley, R. L., Ma, Z., Graham, S., Chaubal, M., Werling, J., et al. (2009) · Nanomedicine · doi:10.2217/nnm.09.71 · Cited by 124
Self-citationHarada, A., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00264-4 · Cited by 114
Tempone, A. G., Perez, D., Rath, S., Vilarinho, A. L., Mortara, R. A., & de Andrade, H. F. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh281 · Cited by 112
Marrow Stromal Cells for Interleukin-2 Delivery in Cancer Immunotherapy
Stagg, J., Lejeune, L., Paquin, A., & Galipeau, J. (2004) · Human Gene Therapy · doi:10.1089/104303404323142042 · Cited by 109
Biju, K., Zhou, Q., Li, G., Imam, S. Z., Roberts, J. L., Morgan, W. W., Clark, R. A., & Li, S. (2010) · Molecular Therapy · doi:10.1038/mt.2010.107 · Cited by 107
Nowacek, A. S., McMillan, J., Miller, R., Anderson, A., Rabinow, B., & Gendelman, H. E. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9198-7 · Cited by 106
Self-citationAdenosine augmentation therapies (AATs) for epilepsy: Prospect of cell and gene therapies
Boison, D. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.03.019 · Cited by 99
Dou, H., Morehead, J., Destache, C. J., Kingsley, J. D., Shlyakhtenko, L. S., Zhou, Y., Chaubal, M. V., Werling, J. O., Kipp, J., Rabinow, B. E., et al. (2006) · Virology · doi:10.1016/j.virol.2006.08.012 · Cited by 90
Self-citationMartínez-Serrano, A., & Björklund, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1858 · Cited by 87
Papaldo, P., Fabi, A., Ferretti, G., Mottolese, M., Cianciulli, A. M., Cocco, B. D., Pino, M. S., Carlini, P., Cosimo, S. D., Sacchi, I., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj110 · Cited by 81
Pawlowski, N. A., Kaplan, G., Abraham, E., & Cohn, Z. A. (1988) · The Journal of experimental medicine · doi:10.1084/jem.168.5.1865 · Cited by 78
Ishihara, T., Izumo, N., Higaki, M., Shimada, E., Hagi, T., Mine, L., Ogawa, Y., & Mizushima, Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.026 · Cited by 70
T lymphocytes as potential therapeutic drug carrier for cancer treatment
Steinfeld, U., Pauli, C., Kaltz, N., Bergemann, C., & Lee, H.-H. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.12.040 · Cited by 70
(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Polyelectrolyte Complex Optimization for Macrophage Delivery of Redox Enzyme Nanoparticles
Zhao, Y., Haney, M. J., Klyachko, N. L., Li, S., Booth, S. L., Higginbotham, S. M., Jones, J., Zimmerman, M. C., Mosley, R. L., Kabanov, A. V., et al. (2011) · Nanomedicine · doi:10.2217/nnm.10.129 · Cited by 64
Self-citationMora, M., Sagristá, M. L., Trombetta, D., Bonina, F. P., Pasquale, A. D., & Saija, A. (2002) · Pharmaceutical Research · doi:10.1023/a:1020440229102 · Cited by 61
Enhanced Oligonucleotide Binding to Self-Assembled Nanofibers
Guler, M. O., Pokorski, J. K., Appella, D. H., & Stupp, S. I. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050053b · Cited by 58
Staedtke, V., Brähler, M., Müller, A., Georgieva, R. T., Bauer, S., Sternberg, N., Voigt, A., Lemke, A., Keck, C. M., Möschwitzer, J. P., et al. (2009) · Small · doi:10.1002/smll.200900919 · Cited by 54
Aoki, H., Kakinuma, K., Morita, K., Kato, M., Uzuka, T., Grinev, I., Takahashi, H. E., & Tanaka, R. (2004) · International Journal of Hyperthermia · doi:10.1080/02656730410001703186 · Cited by 54
Boison, D. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2008.12.001 · Cited by 53
Martínez-Serrano, A., Hantzopoulos, P. A., & Björklund, A. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01258.x · Cited by 52
Delivery of immunostimulatory monoclonal antibodies by encapsulated hybridoma cells
Dubrot, J., Portero, A., Orive, G., Hernández, R. M., Palazón, A., Rouzaut, A., Perez‐Gracia, J. L., Hervás‐Stubbs, S., Pedraz, J. L., & Melero, I. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0888-z · Cited by 45
Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells
Düzgüneş, N., Pretzer, E., Simões, S., Slepushkin, V., Konopka, K., Flasher, D., & de Lima, M. C. P. (1999) · Molecular Membrane Biology · doi:10.1080/096876899294832 · Cited by 45
Red Cell-Mediated Therapy: Opportunities and Challenges
Krantz, A. (1997) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.1997.0119 · Cited by 44
Khan, M. A., Jabeen, R., Nasti, T. H., & Owais, M. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh522 · Cited by 44
In vivo optical imaging using quantum dots for the management of brain tumors
Popescu, M. A., & Toms, S. A. (2006) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.6.6.879 · Cited by 39
Enhanced Vascularization and Survival of Neural Transplants with Ex Vivo Angiogenic Gene Transfer
Casper, D., Engstrom, S. J., Mirchandani, G. R., Pidel, A., Palencia, D., Cho, P. H., Brownlee, M., Edelstein, D., Federoff, H. J., & Sonstein, W. J. (2002) · Cell Transplantation · doi:10.3727/000000002783985828 · Cited by 39
Macrophage Targeted N-(2-Hydroxypropyl)methacrylamide Conjugates for Magnetic Resonance Imaging
Zarabi, B., Nan, A., Zhuo, J., Gullapalli, R. P., & Ghandehari, H. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060072i · Cited by 37
Initial Observations of Cell-Mediated Drug Delivery to the Deep Lung
Kumar, A. B., Glaum, M. C., El‐Badri, N., Mohapatra, S. S., Haller, E. M., Park, S., Patrick, L., Nattkemper, L. A., Vo, D., & Cameron, D. F. (2010) · Cell Transplantation · doi:10.3727/096368910x536491 · Cited by 32
Wang, G., Guan, Y., Jin, X., Jiang, S., Lu, Z., Wu, Y., Li, Y., Li, M., & Luo, F. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06155.x · Cited by 30
Fahmy, T. M., Schneck, J. P., & Saltzman, W. M. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2006.11.010 · Cited by 29
Magnetic Microspheres for the Targeted Controlled Release of Drugs and Diagnostic Agentsa
Ranney, D. F., & HUFFAKER, H. H. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb45795.x · Cited by 24
Chemokine targets in acute brain injury and disease
Anthony, D. C., Blond, D., Dempster, R., & Perry, V. H. (2001) · Progress in brain research · doi:10.1016/s0079-6123(01)32099-x · Cited by 21
Regulatable Acetylcholine-Producing Fibroblasts Enhance Cognitive Performance
Pizzo, D. P., Coufal, N. G., Lortie, M. J., Gage, F. H., & Thal, L. J. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.001 · Cited by 7
Cited by
The blood–brain barrier and blood–tumour barrier in brain tumours and metastases
Arvanitis, C. D., Ferraro, G. B., & Jain, R. K. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0205-x · Cited by 1,792
Nanoparticle uptake: The phagocyte problem
Gustafson, H. H., Holt-Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,411
From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery
Banks, W. A. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.21 · Cited by 1,204
Xue, J., Zhao, Z., Zhang, L., Xue, L., Shen, S., Wen, Y., Wei, Z., Wang, L., Kong, L., Sun, H., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.54 · Cited by 959
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Metadata
- Authors
- Batrakova, E. V., Gendelman, H. E., & Kabanov, A. V.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa Healthcare
- Published
- 2011-02-24
- Volume
- 8
- Issue
- 4
- Pages
- 415-433
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2124723818
- Cited by
- 323
- References
- 104
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.